{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:42:55Z","timestamp":1789753375891,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.anndiagpath.2010.10.004","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T21:29:32Z","timestamp":1299533372000},"page":"162-169","source":"Crossref","is-referenced-by-count":34,"title":["Expression and clinicopathologic significance of glypican 3 in hepatocellular carcinoma"],"prefix":"10.1016","volume":"15","author":[{"given":"Bin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2008-9-5-224","article-title":"Glypicans","volume":"9","author":"Filmus","year":"2008","journal-title":"Genome Biol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0010","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.4161\/cc.7.18.6672","article-title":"The role of glypican-3 in the regulation of body size and cancer","volume":"7","author":"Filmus","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.devcel.2008.03.006","article-title":"Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding","volume":"14","author":"Capurro","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/PAP.0b013e3181992455","article-title":"Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more","volume":"16","author":"Kandil","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0025","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/01.pas.0000213323.97294.9a","article-title":"Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia\u2013like nodules","volume":"30","author":"Libbrecht","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2008.85","article-title":"Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum","volume":"21","author":"Shafizadeh","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/modpathol.2008.26","article-title":"Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study","volume":"21","author":"Ligato","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e318158142f","article-title":"Distinction of hepatocellular carcinoma from benign hepatic mimickers using glypican-3 and CD34 immunohistochemistry","volume":"32","author":"Coston","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0045","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1309\/HCQWPWD50XHD2DW6","article-title":"Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples","volume":"129","author":"Baumhoer","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0050","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/modpathol.2010.105","article-title":"Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation","volume":"23","author":"Ward","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0055","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/PAS.0b013e31815a565a","article-title":"Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary","volume":"32","author":"Esheba","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/modpathol.2008.37","article-title":"Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma","volume":"21","author":"Aviel-Ronen","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2559.2006.02522.x","article-title":"Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein\u2013producing gastric carcinoma","volume":"49","author":"Hishinuma","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0070","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e318194b3ea","article-title":"Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions","volume":"33","author":"Tatrai","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/WMB5PX57Y4P8QCTY","article-title":"Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy","volume":"130","author":"Anatelli","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1746.2009.05988.x","article-title":"Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers","volume":"25","author":"Tangkijvanich","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0085","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/modpathol.3800436","article-title":"The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma","volume":"18","author":"Yamauchi","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0090","series-title":"World Health Organization classification of tumours: pathology and genetics of tumours of the digestive system","first-page":"159","year":"2000"},{"issue":"Suppl 2","key":"10.1016\/j.anndiagpath.2010.10.004_bb0095","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1111\/j.1872-034X.2007.00177.x","article-title":"International consensus on histologic diagnosis of early hepatocellular neoplasia","volume":"37","author":"Wanless","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.humpath.2005.08.019","article-title":"Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma","volume":"37","author":"Aishima","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.humpath.2007.06.004","article-title":"Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma","volume":"39","author":"Abdul-Al","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0110","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.humpath.2006.05.016","article-title":"Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas","volume":"37","author":"Wang","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0115","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/carcin\/bgn091","article-title":"Glypican-3-mediated oncogenesis involves the insulin-like growth factor\u2013signaling pathway","volume":"29","author":"Cheng","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0120","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.4161\/cbt.8.24.9985","article-title":"Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma","volume":"8","author":"Takai","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0125","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/carcin\/bgn111","article-title":"Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses","volume":"29","author":"Liu","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.anndiagpath.2010.10.004_bb0130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/hep.21531","article-title":"Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis","volume":"45","author":"Di Tommaso","year":"2007","journal-title":"Hepatology"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913410001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913410001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T03:55:31Z","timestamp":1560052531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913410001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1092913410001851"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2010.10.004","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}